Immediate Impact
59 standout
Citing Papers
Chronic kidney disease
2025 Standout
Cardiovascular therapeutic targets of sodium-glucose co-transporter 2 (SGLT2) inhibitors beyond heart failure
2025 Standout
Works of Muhammad Mustafa Memon being referenced
Meta-Analysis Evaluating Risk of Hyperkalemia Stratified by Baseline MRA Usage in Patients with Heart Failure Receiving SGLT2 Inhibitors
2023
Sodium-glucose co-transporter 2 inhibitors and cardiovascular outcomes: A systematic review and meta-analysis
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Muhammad Mustafa Memon | 213 | 98 | 66 | 109 | 17 | 347 | |
| Julian Westphal | 227 | 73 | 52 | 89 | 25 | 313 | |
| Isabella Evangelista | 221 | 63 | 68 | 62 | 23 | 383 | |
| E. Roig | 256 | 31 | 61 | 72 | 13 | 306 | |
| Sivakumar Ardhanari | 255 | 20 | 78 | 61 | 22 | 372 | |
| Jacinthe Boulet | 102 | 82 | 57 | 47 | 16 | 312 | |
| Sundararajan Srikanth | 160 | 59 | 91 | 63 | 15 | 360 | |
| Louise Balling | 238 | 209 | 65 | 28 | 19 | 376 | |
| Sithu Win | 337 | 44 | 61 | 88 | 19 | 399 | |
| Maria‐Teresa Olivari | 318 | 83 | 80 | 52 | 13 | 384 | |
| C. Manfredi | 210 | 62 | 31 | 34 | 21 | 352 |
All Works
Login with ORCID to disown or claim papers
Loading papers...